CGC 301
Alternative Names: CGC-301Latest Information Update: 28 Jan 2025
Price :
$50 *
At a glance
- Originator CureGenetics
- Class Gene therapies; Urologics
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Kidney disorders
Most Recent Events
- 07 Jan 2025 Early research in Kidney disorders in China (Parenteral) prior to January 2025 (CureGenetics pipeline, January 2025)